Recombinant Proteins

Descrizione Azione

Beta-galactoside alpha-2,6-sialyltransferase 1, also known as B-cell antigen CD75, Sialyltransferase 1, CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1, ST6GAL1 and SIAT1, is a single-pass type II membrane protein which belongs to the glycosyltransferase 29 family. Sialyltransferases are key enzymes in the biosynthesis of sialoglycoconjugates that catalyze the transfer of sialic residue from its activated form to an oligosaccharidic acceptor. ST6GAL1 / SIAT1 is normally found in the Golgi but which can be proteolytically processed to a soluble form. It is involved in the generation of the cell-surface carbohydrate determinants and differentiation antigens HB-6, CDw75, and CD76. β-Galactoside α2,6-sialyltransferases ST6GAL1 and ST6GAL2 are the two unique members of the ST6GAL family described in higher vertebrates. ST6GAL1 / SIAT1 transfers sialic acid from the donor of substrate CMP-sialic acid to galactose containing acceptor substrates.

Codice: PKSM040506_100μg Confezionamento: 100μg
Dettagli
Codice: PKSM040489_50μg Confezionamento: 50μg
Dettagli

Alpha-N-acetylgalactosaminide alpha -2,6-sialyltransferase 2, is a type II membrane protein localized in the Golgi network and catalyzes 2,6-sialylation of the Tn antigen. Sialyl-Tn antigen is highly expressed in several human carcinomas and is associated with carcinoma aggressiveness and poor prognosis. It has been reported that disregulation of this gene is involved in the pathogenesis of IgA nephropathy, a common kidney disease that occurs when antibody IgA accumulates in kidneys (4). The enzyme may also be used to synthesize a cancer vaccine.

Codice: PKSM041361_50μg Confezionamento: 50μg
Dettagli

Alpha-N-acetylgalactosaminide alpha -2,6-sialyltransferase 2, is a type II membrane protein localized in the Golgi network and catalyzes 2,6-sialylation of the Tn antigen. Sialyl-Tn antigen is highly expressed in several human carcinomas and is associated with carcinoma aggressiveness and poor prognosis. It has been reported that disregulation of this gene is involved in the pathogenesis of IgA nephropathy, a common kidney disease that occurs when antibody IgA accumulates in kidneys (4). The enzyme may also be used to synthesize a cancer vaccine.

Codice: PKSM041361_10μg Confezionamento: 10μg
Dettagli
Codice: PDEM100191_500μg Confezionamento: 500μg
Dettagli
Codice: PDEM100191_20μg Confezionamento: 20μg
Dettagli
Codice: PDEM100191_1mg Confezionamento: 1mg
Dettagli
Codice: PDEM100191_100μg Confezionamento: 100μg
Dettagli
Codice: PDEM100123_100μg Confezionamento: 100μg
Dettagli
Codice: PDEM100123_1mg Confezionamento: 1mg
Dettagli
Codice: PDEM100123_20μg Confezionamento: 20μg
Dettagli
Codice: PDEM100123_500μg Confezionamento: 500μg
Dettagli